KYN News & Analysis

Kyntra Bio Inc (KYN) Form 4 Filed on June 17

On June 17, Kyntra Bio Inc (KYN) filed Form 4 with the SEC, reflecting insider trading activity. The form disclosed stock transactions and potential changes in beneficial ownership among executive officers. These filings are significant as they provide transparency on insider actions which can influence investor perceptions. The specific details of the stock transactions made on this date were not included in the article.